Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall crestorSeveral consumer advocate groups around the world are putting considerable pressure on their respective government agencies to institute a Crestor recall. Crestor is a prescription statin drug that was approved by the US Federal Drug Administration in August of 2003 to treat patients with high cholesterol. Touted as a “super statin,” Crestor sales have yielded more than $600 million in revenue in 2004 alone. AstraZeneca''s aggressive marketing strategies have elicited over 11 million prescriptions of Crestor to be sold to patients suffering from high cholesterol since Crestor''s approval in 2003.
As of the beginning of November 2004, twenty nine Crestor patients have developed the serious degenerative muscle condition known as Rhabdomyolosis. All of these patients have suffered serious kidney damage as a result of this condition. In light of these cases, consumer advocacy groups are calling for a Crestor recall.
Public Citizen, a reputable consumer advocate group in the United States, has made several statements calling for a Crestor recall since the drug was approved for sale in the United States. Studies show that people who are taking Crestor are seventy five times more likely to develop rhabdomyolosis than the general population. Many groups rightly feel that these potential risks outweigh the intended benefits of taking Crestor, demanding that the FDA institute a drug recall.
Rhabdomyolosis is an acute rapidly developing potentially fatal disease that develops when muscle fibers are destroyed and toxic chemicals are released into the bloodstream. This can cause a decrease in the amount of blood that the body circulates. The chemicals that are released with the breakdown of muscle tissues are toxic to the kidneys. Rhabdomyolosis can cause acute renal failure in patients along with damage to other internal organs.
Advocates of a Crestor recall are pressuring the FDA to remove this drug from the US market. AstraZeneca continues to maintain that Crestor is just as safe as other statin drugs. The company has taken no steps to protect their patients from the potentially harmful side effects that are caused by their product and have done nothing to suggest that they are considering a Crestor recall.
In regards to the safety of other statin drugs, one such medication has already been recalled and pulled from the market for causing Rhabdomyolosis. Baycol, made by Bayer, was recalled in August of 2001 after several reports that this statin caused an increased risk of kidney failure and the deadly muscle condition, Rhabdomyolosis.
In light of the pressure for a Crestor recall by consumer advocates, the FDA has agreed to monitor reports of safety problems associated with Crestor use, but has made no indication that they intend to issue a Crestor recall. If you have been injured by Crestor use, you may wish to speak to a legal professional who can help you recover what you''ve lost as a result of your Crestor injuries.
The consumer advocacy group Public Citizen submitted a petition to the FDA a year ago asking the agency to immediately withdraw the anti-cholesterol drug Crestor, but the agency has denied its request.
Crestor belongs to a group of drugs ...
The FDA has announced that Crestor is being relabeled to add a warning that starter doses should be reduced in Asian-American patients, as well as some other higher risk patients.
A clinical trial found that levels in Asian patients were d...
The FDA announced a revised drug labeling for the cholesterol-lowering drug Crestor would be added, warning of the serious muscle damage called rhabdomyolysis.
A clinical trial found levels of Crestor in Asian patients were double those of C...